DDrare: Database of Drug Development for Rare Diseases

Iron chelating intervention (DrugBank: Iron)

1 disease

ID	Disease name (Link within this page)	Number of trials
18	Spinocerebellar degeneration	1

18. Spinocerebellar degeneration [ 59 clinical trials, 78 drugs, (DrugBank: 28 drugs), 44 drug target genes, 59 drug target pathways]

Searched query = "Spinocerebellar degeneration", "SCD", "Spinocerebellar ataxia type I", "SCA1", "Spinocerebellar ataxia type II", "SCA2", "Spinocerebellar ataxia type III", "SCA3", "Machado-Joseph disease", "Spinocerebellar ataxia type VI", "SCA6", "Spinocerebellar ataxia type VII", "SCA7", "Spinocerebellar ataxia type X", "SCA10", "Spinocerebellar ataxia type XII", "SCA12", "Dentatorubural pallidoluysian atrophy", "Dentatorubropallidoluysial atrophy", "DRPLA", "Naito-Koyanagi disease", "Friedreich ataxia", "FRDA", "Ataxia with vitamin E deficiency", "AVED", "Early-onset ataxia with ocular motor ataxia and hypoalbuminemia", "EOAH"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 59 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00224640 (ClinicalTrials.gov)	March 2005	16/9/2005	Iron-Chelating Therapy and Friedreich Ataxia	Effect of Iron-Chelating Therapy in Friedreich Ataxia. Study Phase I/II	Friedreich Ataxia	Drug: Iron chelating intervention	Assistance Publique - Hôpitaux de Paris	NULL	Completed	13 Years	N/A	Both	15	Phase 1;Phase 2	France